<DOC>
	<DOC>NCT02543099</DOC>
	<brief_summary>The purpose of this study is to assess the clinical efficacy and safety of policosanol on elderly patients with endothelial dysfunction</brief_summary>
	<brief_title>Efficacy and Safety Study of Policosanol</brief_title>
	<detailed_description>100 selected elderly patients with endothelial dysfunction were randomized to two groups,Group1:received policosanol 20mg qd;Group2:received placebo 20mg qd；endothelial function was tested by peripheral arterial tonometry(PAT) before and after 6 months' treatment with policosanol or placebo respectively; Endothelial dysfunction is defined as reactive hyperemia index(RHI)&lt; 1.67; The aim of this study is to assess the clinical efficacy and safety of policosanol on elderly patients with endothelial dysfunction.</detailed_description>
	<mesh_term>Policosanol</mesh_term>
	<criteria>1. Age over 60 years old； 2. Patients with endothelial dysfunction 3. Provision of informed consent prior to any study specific procedures. 1. Acute myocardial infarction ,severe trauma , major operation or stroke within six months; 2. Tumor or inflammatory diseases 3. Known allergies to policosanol 4. Life expectancy less than 1 year 5. secondary dyslipidemia 6.taking other experimental medicine within six months;</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>endothelial function</keyword>
	<keyword>policosanol</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>